CAPR Capricor Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 14, 2026
$8,95
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$2,9652 haftanın en düşüğü
$40,3752 haftanın en yükseği
Piyasa Değeri (MRQ)
$520M
P/E
-4.0
Hisse Başına Kâr
$-2.26
Gelir
$0
rozetleriniz
52 Haftlık Aralık
$3–$40
Analist Derecelendirmesi
HOLD
Fiyat Hedefi
$27
P/E
-4.0
ROE
-51.1%
Net Kâr Marjı
·
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
CAPR Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$8.95
Piyasa Değeri (MRQ)
$520M
P/E
-4.0
Hisse Başına Kâr
$-2.26
Gelir
$0
ROE
-51.1%
52 Haftlık Aralık
$3–$40
CAPR Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
Hisse bölünmeleri
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 05 Haziran 2019 | 1-for-10 | Ters |
| 21 Kasım 2013 | 1-for-50 | Ters |
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$02016-12-31 → 2025-12-31
Hisse Başına Kâr$-2.262016-12-31 → 2025-12-31
Serbest Nakit Akışı$-73M2016-12-31 → 2025-12-31
Net kar marjı·2016-12-31 → 2024-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | CAPR | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E | -4.05Y ort. ≈-7.5 | ≈-7.5 | · | · | |
| F/D (MRQ) | 2.15Y ort. ≈5.4 | ≈5.4 | 3.1 | Aşırı değerli | |
| Fiyat / Serbest Nakit Akışı (TTM) | -4.55Y ort. ≈-2.8 | ≈-2.8 | · | · | |
| Fiyat / Nakit Akışı (TTM) | -5.05Y ort. ≈-6.0 | ≈-6.0 | · | · | |
| Price / Tangible Book (Fiyat / Maddi Defter Değeri) | 1.75Y ort. ≈5.4 | ≈5.4 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | CAPR | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| ROA | -39.9%5Y ort. ≈-46.5% | ≈-46.5% | -39.7% | Aynı seviyede | |
| ROE | -51.1%5Y ort. ≈-115.0% | ≈-115.0% | -48.4% | Aynı seviyede | |
| ROIC | -35.4% | · | -37.6% | En üst düzey |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | CAPR | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 7.35Y ort. ≈5.8 | ≈5.8 | 10.7 | Düşük likidite | |
| Quick Ratio (Cari Oran) | 8.05Y ort. ≈5.3 | ≈5.3 | 6.4 | Düşük likidite |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | CAPR | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | -11.6%5Y ort. ≈449.0% | ≈449.0% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | 349.7% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | CAPR | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 0.05Y ort. ≈0.1 | ≈0.1 | 0.0 | Zayıf | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$0.00 | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-11.0%
Sonraki Rapor
Kas 09, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 13, 2026 | $-0.70 | $-0.60 | -16.3% |
| 31 Mart 2026 | May 11, 2026 | $-0.59 | $-0.54 | -8.8% |
| 31 Aralık 2025 | $-0.62 | $-0.55 | -12.6% | |
| 30 Eylül 2025 | $-0.54 | $-0.56 | 3.3% | |
| 30 Haziran 2025 | $-0.57 | $-0.48 | -19.2% | |
| 31 Mart 2025 | $-0.53 | $-0.32 | -64.1% | |
| 31 Aralık 2024 | $-0.16 | $-0.27 | 40.4% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $22M | $25M | $3M | $244.9K | $310.2K | $1M | $2M | $3M | $4M | $6M | $5M | |
| R&D Expense | $84M | $50M | $36M | $22M | $14M | $8M | $5M | $12M | $11M | $16M | $14M | $8M | |
| SG&A Expense | $24M | $15M | $13M | $10M | $8M | $6M | $4M | $5M | $5M | $5M | $4M | $3M | |
| Operating Expenses | $108M | $65M | $49M | $32M | $21M | $14M | $9M | $17M | $16M | $21M | $18M | $11M | |
| Operating Income | $-108M | $-43M | $-24M | $-30M | $-21M | $-14M | $-8M | $-15M | $-13M | $-17M | $-13M | $-6M | |
| Interest Expense | · | · | · | · | · | · | · | $0 | $398.8K | $344.7K | $248.6K | $200.5K | |
| Other Non-op | $3M | $2M | $2M | $677.9K | $915.9K | $32.9K | $92.1K | $136.0K | $15M | $-2M | $-245.5K | $-198.6K | |
| Pretax Income | $-105M | $-40M | · | · | · | · | · | · | · | · | · | · | |
| Income Tax | $1.6K | $1.6K | · | · | · | · | · | · | · | · | · | · | |
| Net Income | $-105M | $-40M | $-22M | $-29M | $-20M | $-14M | $-8M | $-15M | $2M | $-19M | $-13M | $-6M | |
| EPS (Basic) | $-2.26 | $-1.15 | $-0.83 | $-1.18 | $-0.87 | $-0.88 | · | · | $0.10 | $-1.01 | · | · | |
| EPS (Diluted) | $-2.26 | $-1.15 | $-0.83 | $-1.18 | $-0.87 | $-0.88 | · | $-0.52 | $0.09 | $-1.01 | · | · | |
| Shares (Basic) | 46,478,416 | 35,218,628 | 26,778,360 | 24,552,688 | 23,089,323 | 15,571,056 | 3,711,333 | 2,941,084 | 23,193,278 | 18,551,013 | · | · | |
| Shares (Diluted) | 46,478,416 | 35,218,628 | 26,778,360 | 24,552,688 | 23,089,323 | 15,571,056 | 3,711,333 | 2,941,084 | 26,788,076 | 18,551,013 | · | · | |
| EBITDA | $-106M | $-41M | $-23M | $-29M | $-21M | $-14M | $-8M | · | $-13M | $-17M | $-13M | $-6M |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $288M | $11M | $15M | $10M | $35M | $33M | $4M | $4M | $6M | $3M | $6M | $8M | |
| Short-term Investments | · | $140M | $25M | $32M | $0 | · | $6M | $3M | $8M | $13M | $8M | $0 | |
| Prepaid Expense | $5M | $2M | $995.8K | $919.9K | $1M | $1M | $571.4K | $724.2K | $501.2K | $342.9K | $210.6K | $235.5K | |
| Current Assets | $323M | $163M | $51M | $43M | $36M | $34M | $11M | $8M | $16M | $18M | $14M | $12M | |
| PP&E (Net) | $18M | $6M | $6M | $5M | $2M | $850.8K | $442.8K | $574.2K | $372.1K | $435.3K | $318.6K | $229.5K | |
| PP&E (Gross) | $23M | $9M | $8M | $6M | $3M | $2M | $1M | $1M | $713.7K | $686.0K | $492.3K | $341.0K | |
| Accum. Depreciation | $5M | $3M | $2M | $1M | $756.7K | $718.6K | $579.0K | $456.0K | $341.6K | $250.7K | $173.7K | $111.6K | |
| Intangibles | · | · | · | · | $0 | $2.2K | $6.5K | $49.8K | $93.0K | $142.3K | $191.0K | $239.8K | |
| Total Assets | $356M | $170M | $59M | $50M | $41M | $35M | $11M | $9M | $16M | $19M | $16M | $14M | |
| Accounts Payable | $2M | $3M | $6M | $5M | $3M | $3M | $898.0K | $1M | $1M | $3M | $3M | $2M | |
| Accrued Liabilities | $16M | $5M | · | · | · | · | · | · | · | · | · | · | |
| Short-term Debt | · | · | · | · | $0 | $246.7K | $0 | · | · | · | · | · | |
| Current Liabilities | $36M | $21M | $31M | $24M | $4M | $3M | $898.0K | $1M | $2M | $5M | $7M | $6M | |
| Capital Leases | $14M | $616.3K | $1M | $2M | $2M | $0 | · | · | · | · | · | · | |
| Total Liabilities | $50M | $25M | $36M | $38M | $10M | $6M | $4M | $5M | $5M | $23M | $17M | $20M | |
| Total Debt | · | · | · | · | $0 | $246.7K | · | · | · | · | · | · | |
| Common Stock | $57.4K | $45.6K | $31.1K | $25.2K | $24.2K | $20.6K | $5.2K | $3.1K | $26.3K | $21.4K | $16.3K | $11.7K | |
| Retained Earnings | $-305M | $-200M | $-159M | $-137M | $-108M | $-88M | $-74M | $-67M | $-52M | $-54M | $-35M | $-22M | |
| AOCI | $283.2K | $1M | $235.8K | $105.2K | $0 | $0 | $-757 | $12.4K | $11.6K | $3.5K | $9.4K | $0 | |
| Stockholders' Equity | $306M | $145M | $23M | $12M | $31M | $28M | $7M | $5M | $11M | $-4M | $-1M | $-6M | |
| Liabilities + Equity | $356M | $170M | $59M | $50M | $41M | $35M | $11M | $9M | $16M | $19M | $16M | $14M | |
| Shares Outstanding | 57,370,909 | 45,582,288 | 31,148,320 | 25,241,402 | 24,185,001 | 20,577,123 | 5,227,398 | 3,138,748 | 26,270,491 | 21,399,019 | 16,254,985 | 11,707,051 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $1M | $1M | $533.1K | $245.7K | $143.9K | $172.0K | $157.7K | $144.2K | $125.7K | $110.9K | $41.9K | |
| Stock-based Comp | · | $10M | $7M | $4M | $3M | $2M | $701.0K | $2M | $2M | $2M | $2M | $496.9K | |
| Amort. of Intangibles | · | · | · | $0 | $2.2K | $4.3K | $43.3K | $43.3K | $49.2K | $48.7K | $48.7K | $10.7K | |
| Other Non-cash | $33M | $-11M | $-12M | $29M | $1.8K | $2M | $-52.6K | · | $-19M | $917.0K | $356.0K | $7M | |
| Operating Cash Flow | $-70M | $-40M | $-26M | $5M | $-17M | $-10M | $-7M | $-14M | $-14M | $-14M | $-11M | $958.6K | |
| CapEx | $3M | $1M | $1M | $2M | $1M | $547.6K | $0 | $316.5K | $32.2K | $192.0K | $129.7K | $162.7K | |
| Investing Cash Flow | $97M | $-116M | $5M | $-35M | $-1M | $5M | $-3M | $5M | $5M | $-5M | · | · | |
| Debt Issued | · | · | · | · | · | · | · | $0 | $500.0K | $5M | $0 | $5M | |
| Net Debt Issued | · | · | · | · | · | · | · | · | $500.0K | $5M | $0 | $5M | |
| Stock Issued | $237M | $152M | $26M | $5M | $20M | $27M | $9M | $7M | $11M | $14M | $16M | $0 | |
| Stock Repurchased | · | · | · | · | · | $0 | $193 | $0 | · | · | · | · | |
| Net Stock Activity | $237M | $152M | $26M | $5M | $20M | $27M | $9M | · | $11M | $14M | $16M | · | |
| Financing Cash Flow | $249M | $153M | $26M | $5M | $20M | $33M | $9M | $7M | $12M | $19M | · | · | |
| Net Change in Cash | · | · | · | · | · | · | · | · | · | $-2M | $-2M | $6M | |
| Taxes Paid | $1.6K | $1.6K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Free Cash Flow | $-73M | $-41M | $-27M | $3M | $-18M | $-11M | $-7M | · | $-14M | $-16M | $-11M | $772.1K |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -191.1% | -95.6% | -1163.9% | -8549.9% | -4412.6% | -769.5% | · | -482.4% | -424.6% | -228.6% | -125.7% | |
| Net Margin | · | -181.7% | -88.5% | -1137.4% | -8175.9% | -4401.9% | -760.4% | · | 91.2% | -470.3% | -233.0% | -129.9% | |
| EBITDA Margin | · | -184.7% | -91.4% | -1143.0% | -8449.5% | -4366.2% | -752.4% | · | -477.0% | -421.4% | -226.6% | -124.8% | |
| ROA | -39.9% | -35.3% | -41.0% | -63.5% | -52.7% | -59.7% | -75.1% | · | 13.9% | -108.0% | -86.6% | -64.9% | |
| ROE | -51.1% | -37.9% | -214.2% | -213.3% | -58.8% | -46.6% | -146.8% | · | 67.3% | 747.1% | 353.2% | 183.3% | |
| ROIC | -35.4% | · | · | · | · | · | · | · | · | · | · | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.0 | 7.8 | 1.6 | 1.8 | 8.8 | 11.3 | 11.7 | · | 9.4 | 3.7 | 2.1 | 1.8 | |
| Quick Ratio | 8.0 | 7.2 | 1.3 | 1.8 | 8.4 | 11.0 | 11.0 | · | 8.5 | 3.3 | 2.1 | 1.3 | |
| Debt / Equity | · | · | · | · | 0.0 | 0.0 | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | -32.3 | -49.3 | -50.7 | -30.0 |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.2 | 0.5 | 0.1 | 0.0 | 0.0 | 0.1 | · | 0.2 | 0.2 | 0.4 | 0.5 |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.33 | $3.19 | $0.73 | $0.47 | $1.30 | $1.37 | $1.31 | · | $0.43 | $-0.19 | $-0.06 | $-0.53 | |
| Revenue / Share | $0.00 | $0.63 | $0.94 | $0.10 | $0.01 | $0.02 | $0.27 | · | $0.10 | · | · | · | |
| Cash Flow / Share | $-1.50 | $-1.14 | $-0.96 | $0.20 | $-0.73 | $-0.65 | $-1.84 | · | $-0.53 | · | · | · | |
| Cash / Share | $5.02 | $0.25 | $0.47 | $0.38 | $1.44 | $1.59 | $0.75 | · | $0.23 | $0.15 | $0.34 | $0.69 | |
| EPS (TTM) | $-2.26 | $-1.15 | $-0.83 | $-1.18 | $-0.87 | $-0.88 | · | $-0.52 | $0.09 | $-1.01 | · | · |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | -11.6% | 886.8% | 941.9% | -21.1% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | · | 349.7% | 332.9% | · | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $22M | $25M | $3M | $244.9K | $310.2K | $1M | $2M | $3M | $4M | $6M | $5M | |
| Net Income TTM | $-105M | $-40M | $-22M | $-29M | $-20M | $-14M | $-8M | $-15M | $2M | $-19M | $-13M | $-6M | |
| Market Cap | $1.66B | $629M | $152M | $97M | $71M | $71M | $7M | · | $415M | $569M | $499M | $439M | |
| Enterprise Value | · | · | · | · | $36M | $38M | · | · | · | · | · | · | |
| P/E | -12.8 | -12.0 | -5.9 | -3.3 | -3.4 | -3.9 | · | -7.9 | 175.6 | -26.3 | · | · | |
| P/S | · | 28.2 | 6.0 | 38.2 | 289.4 | 227.5 | 6.7 | · | 155.7 | 142.4 | 90.4 | 91.7 | |
| P/B | 5.4 | 4.3 | 6.7 | 8.3 | 2.3 | 2.5 | 1.0 | · | 37.0 | -142.2 | -483.7 | -70.3 | |
| P / Tangible Book | 5.4 | 4.3 | 6.7 | 8.3 | 2.3 | 2.5 | · | · | · | · | · | · | |
| P / Cash Flow | -23.7 | -15.7 | -6.0 | 19.8 | -4.2 | -7.0 | -1.0 | · | -29.2 | -36.0 | -46.1 | 458.0 | |
| P / FCF | -22.8 | -15.3 | -5.7 | 33.4 | -3.9 | -6.7 | -1.0 | · | -29.1 | -35.6 | -45.6 | 568.6 | |
| EV / EBITDA | · | · | · | · | -1.7 | -2.8 | · | · | · | · | · | · | |
| EV / FCF | · | · | · | · | -2.0 | -3.6 | · | · | · | · | · | · | |
| EV / Revenue | · | · | · | · | 146.9 | 123.0 | · | · | · | · | · | · | |
| Earnings Yield | -7.8% | -8.3% | -17.0% | -30.6% | -29.7% | -25.7% | · | -12.7% | 0.57% | -3.8% | · | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | $11M | $2M | $4M | $5M | $12M | $6M | $4M | $3M | $959.9K | $2M | |
| R&D Expense | $29M | $27M | $23M | $20M | $22M | $19M | $15M | $12M | $13M | $11M | $10M | $10M | $9M | $8M | $6M | $6M | |
| SG&A Expense | $14M | $9M | $6M | $6M | $6M | $6M | $4M | $3M | $3M | $4M | $3M | $3M | $3M | $4M | $3M | $3M | |
| Operating Expenses | $43M | $37M | $29M | $26M | $28M | $25M | $19M | $15M | $16M | $15M | $13M | $13M | $12M | $11M | $9M | $8M | |
| Operating Income | $-43M | $-37M | $-29M | $-26M | $-28M | $-25M | $-8M | $-13M | $-12M | $-10M | $-1M | $-7M | $-8M | $-8M | $-8M | $-6M | |
| Other Non-op | $2M | $3M | $-1M | $2M | $2M | $591.4K | $581.2K | $453.2K | $591.4K | $471.8K | $519.2K | $474.0K | $380.7K | $416.4K | $345.4K | $106.6K | |
| Pretax Income | $-41M | $-34M | · | · | $-26M | $-24M | · | · | · | · | · | · | · | · | · | · | |
| Income Tax | $1.6K | $0 | · | · | $1.6K | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Income | $-41M | $-34M | $-30M | $-25M | $-26M | $-24M | $-7M | $-13M | $-11M | $-10M | $-762.1K | $-6M | $-7M | $-8M | $-8M | $-6M | |
| EPS (Basic) | $-0.70 | $-0.59 | $-0.62 | $-0.54 | $-0.57 | $-0.53 | $-0.11 | $-0.38 | $-0.35 | $-0.31 | $0.02 | $-0.25 | $-0.29 | $-0.31 | $-0.31 | $-0.26 | |
| EPS (Diluted) | $-0.70 | $-0.59 | $-0.62 | $-0.54 | $-0.57 | $-0.53 | $-0.11 | $-0.38 | $-0.35 | $-0.31 | $0.02 | $-0.25 | $-0.29 | $-0.31 | $-0.31 | $-0.26 | |
| Shares (Basic) | 57,926,347 | 57,434,267 | · | 45,716,151 | 45,709,071 | 45,636,633 | · | 33,090,063 | 31,841,964 | 31,354,629 | · | 25,817,676 | 25,335,342 | 25,247,354 | · | 24,431,787 | |
| Shares (Diluted) | 57,926,347 | 57,434,267 | · | 45,716,151 | 45,709,071 | 45,636,633 | · | 33,090,063 | 31,841,964 | 31,354,629 | · | 25,817,676 | 25,335,342 | 25,247,354 | · | 24,431,787 | |
| EBITDA | $-43M | $-36M | · | $-26M | $-28M | $-25M | · | $-13M | $-12M | $-10M | · | $-7M | $-8M | $-8M | · | $-6M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $21M | $105M | $288M | $20M | $23M | $29M | $11M | $68M | $11M | $6M | $15M | $9M | $10M | $11M | $10M | $8M | |
| Short-term Investments | · | · | · | $79M | $100M | $116M | · | $17M | $19M | $34M | $25M | $20M | $28M | $35M | $32M | $38M | |
| Prepaid Expense | $4M | $4M | $5M | $2M | $1M | $1M | $2M | $385.1K | $837.2K | $1M | $995.8K | $458.4K | $583.8K | $875.1K | $919.9K | $343.7K | |
| Current Assets | $242M | $283M | $323M | $101M | $124M | $146M | $163M | $86M | $31M | $41M | $51M | $30M | $39M | $47M | $43M | $48M | |
| PP&E (Net) | $36M | $29M | $18M | $11M | $8M | $6M | $6M | $5M | $6M | $6M | $6M | $5M | $5M | $5M | $5M | $4M | |
| PP&E (Gross) | $42M | $34M | $23M | $16M | $12M | $10M | $9M | $9M | $8M | $8M | $8M | $7M | $6M | $6M | $6M | $5M | |
| Accum. Depreciation | $6M | $6M | $5M | $5M | $4M | $4M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | $1M | $1M | |
| Total Assets | $369M | $326M | $356M | $126M | $134M | $154M | $170M | $93M | $38M | $49M | $59M | $37M | $46M | $54M | $50M | $54M | |
| Accounts Payable | $3M | $4M | $2M | $3M | $5M | $5M | $3M | $7M | $6M | $6M | $6M | $7M | $5M | $5M | $5M | $4M | |
| Accrued Liabilities | $16M | $11M | $16M | $10M | $7M | $4M | $5M | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $33M | $34M | $36M | $28M | $28M | $22M | $21M | $20M | $22M | $26M | $31M | $33M | $35M | $37M | $24M | $23M | |
| Capital Leases | $90M | $14M | $14M | $14M | $194.6K | $407.4K | $616.3K | $834.9K | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | |
| Total Liabilities | $123M | $48M | $50M | $43M | $29M | $26M | $25M | $25M | $27M | $31M | $36M | $39M | $43M | $48M | $38M | $39M | |
| Common Stock | $58.1K | $57.7K | $57.4K | $45.7K | $45.7K | $45.7K | $45.6K | $40.3K | $32.0K | $31.6K | $31.1K | $25.9K | $25.8K | $25.3K | $25.2K | $24.7K | |
| Retained Earnings | $-380M | $-339M | $-305M | $-275M | $-250M | $-224M | $-200M | $-193M | $-180M | $-169M | $-159M | $-159M | $-152M | $-145M | $-137M | $-129M | |
| AOCI | $-163.5K | $-253.7K | $283.2K | $844.1K | $1M | $2M | $1M | $96.2K | $155.0K | $307.7K | $235.8K | $113.2K | $179.7K | $95.0K | $105.2K | $122.5K | |
| Stockholders' Equity | $246M | $279M | $306M | $84M | $105M | $128M | $145M | $68M | $12M | $18M | $23M | $-2M | $3M | $6M | $12M | $15M | |
| Liabilities + Equity | $369M | $326M | $356M | $126M | $134M | $154M | $170M | $93M | $38M | $49M | $59M | $37M | $46M | $54M | $50M | $54M | |
| Shares Outstanding | 58,108,989 | 57,664,673 | 57,370,909 | 45,716,975 | 45,711,975 | 45,676,887 | 45,582,288 | 40,332,392 | 31,983,927 | 31,600,183 | 31,148,320 | 25,855,070 | 25,764,312 | 25,255,154 | 25,241,402 | 24,702,684 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $561.8K | $534.7K | $502.6K | $494.7K | $486.3K | $405.4K | $375.7K | $361.2K | $356.9K | $331.4K | $307.6K | $276.5K | $254.7K | $230.1K | $191.6K | $137.0K | |
| Stock-based Comp | · | · | · | · | · | · | · | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $1M | $1M | |
| Other Non-cash | · | $4M | · | · | · | $18M | · | · | · | $5M | · | · | · | $10M | · | · | |
| Operating Cash Flow | $-31M | $-29M | $-24M | $-20M | $-20M | $-6M | $-15M | $-12M | $-12M | $-1M | $-12M | $-9M | $-9M | $4M | $-7M | $-6M | |
| CapEx | $4M | $5M | $2M | $55.8K | $287.7K | $896.0K | $488.8K | $9.1K | $60.3K | $608.6K | $558.6K | $269.5K | $135.9K | $347.7K | $694.0K | $557.6K | |
| Investing Cash Flow | $-49M | $-155M | $43M | $16M | $15M | $24M | $-123M | $2M | $15M | $-10M | $-6M | $8M | $6M | $-3M | $5M | $-4M | |
| Stock Issued | · | · | · | · | · | · | $81M | $67M | $2M | $2M | $23M | $221.1K | $2M | $0 | $3M | $2M | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $2M | · | · | · | · | · | · | |
| Financing Cash Flow | $-4M | $1M | $249M | $7.0K | $19.6K | $50.4K | $81M | $67M | $2M | $2M | $23M | $221.1K | $2M | $3.9K | $3M | $2M | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | |
| Free Cash Flow | · | $-34M | · | · | · | $-7M | · | · | · | $-2M | · | · | · | $4M | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | -575.2% | -291.9% | -209.2% | · | -111.0% | -197.8% | -274.0% | · | -407.0% | |
| Net Margin | · | · | · | · | · | · | · | -555.2% | -277.0% | -199.6% | · | -103.3% | -188.0% | -260.1% | · | -400.3% | |
| EBITDA Margin | · | · | · | · | · | · | · | -575.2% | -291.9% | -202.5% | · | -111.0% | -197.8% | -266.3% | · | -407.0% | |
| ROA | -16.2% | -14.1% | · | -22.4% | -30.2% | -24.0% | · | -19.3% | -26.1% | -19.0% | · | -14.0% | -14.2% | -13.1% | · | -13.1% | |
| ROE | -23.2% | -16.7% | · | -32.3% | -44.5% | -33.4% | · | -37.8% | -154.6% | -79.5% | · | -93.7% | -68.7% | -50.4% | · | -24.4% | |
| ROIC | -17.4% | -13.2% | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.3 | 8.4 | · | 3.6 | 4.4 | 6.5 | · | 4.2 | 1.4 | 1.6 | · | 0.9 | 1.1 | 1.3 | · | 2.0 | |
| Quick Ratio | 0.6 | 3.1 | · | 3.5 | 4.3 | 6.5 | · | 4.2 | 1.3 | 1.5 | · | 0.9 | 1.1 | 1.2 | · | 2.0 |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | 0.0 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.0 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $4.24 | $4.83 | · | $1.83 | $2.30 | $2.79 | · | $1.69 | $0.36 | $0.58 | · | $-0.07 | $0.11 | $0.25 | · | $0.62 | |
| Revenue / Share | · | · | · | · | · | · | · | $0.07 | $0.12 | $0.16 | · | $0.24 | $0.15 | $0.12 | · | $0.07 | |
| Cash Flow / Share | · | $-0.51 | · | · | · | $-0.14 | · | · | · | $-0.04 | · | · | · | $0.17 | · | · | |
| Cash / Share | $0.36 | $1.83 | · | $0.43 | $0.51 | $0.63 | · | $1.70 | $0.33 | $0.20 | · | $0.35 | $0.38 | $0.42 | · | $0.34 | |
| EPS (TTM) | $-2.45 | $-2.32 | · | $-1.75 | $-1.59 | $-1.37 | · | $-1.02 | $-0.89 | $-0.83 | · | $-1.16 | $-1.17 | $-1.17 | · | $-1.13 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $22M | $22M | · | $22M | $22M | $22M | · | $23M | $27M | $27M | · | $14M | $9M | · | · | · | |
| Net Income TTM | $-129M | $-115M | · | $-82M | $-70M | $-55M | · | $-34M | $-28M | $-24M | · | $-29M | $-29M | $-29M | · | $-27M | |
| Market Cap | $1.40B | $1.75B | · | $330M | $454M | $433M | · | $613M | $153M | $215M | · | $88M | $123M | $107M | · | $148M | |
| P/E | -9.8 | -13.1 | · | -4.1 | -6.2 | -6.9 | · | -14.9 | -5.4 | -8.2 | · | -2.9 | -4.1 | -3.6 | · | -5.3 | |
| P/S | 62.8 | 78.7 | · | 14.8 | 20.4 | 19.5 | · | 26.4 | 5.6 | 7.9 | · | 6.3 | 13.0 | · | · | · | |
| P/B | 5.7 | 6.3 | · | 3.9 | 4.3 | 3.4 | · | 9.0 | 13.3 | 11.6 | · | -49.5 | 45.1 | 17.2 | · | 9.6 | |
| P / Tangible Book | 5.7 | 6.3 | · | 3.9 | 4.3 | 3.4 | · | 9.0 | 13.3 | 11.6 | · | · | 45.1 | 17.2 | · | 9.6 | |
| P / Cash Flow | · | -59.9 | · | · | · | -67.4 | · | · | · | -169.2 | · | · | · | 25.3 | · | · | |
| Earnings Yield | -10.2% | -7.6% | · | -24.3% | -16.0% | -14.4% | · | -6.7% | -18.7% | -12.2% | · | -33.9% | -24.5% | -27.7% | · | -18.8% |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $0 | $22M | $25M | $3M | $244.9K |
| Faaliyet Kâr Marjı % | · | -191.1% | -95.6% | -1163.9% | -8549.9% |
| Net Gelir | $-105M | $-40M | $-22M | $-29M | $-20M |
| Seyreltilmiş Hisse Başı Kâr | $-2.26 | $-1.15 | $-0.83 | $-1.18 | $-0.87 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | · | · | · | · | 0.0 |
| Cari Oran | 9.0 | 7.8 | 1.6 | 1.8 | 8.8 |
| Cari Oran | 8.0 | 7.2 | 1.3 | 1.8 | 8.4 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-73M | $-41M | $-27M | $3M | $-18M |
Kurumsal Sahipler (13F) 206 dosya · $1.2B toplam · Tarih itibarıyla 30 Eylül 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
206
Tutulan Değer
$1.2B
Yeni pozisyonlar
34
Çıkan pozisyonlar
31
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 34 (-42 önceki Ç'ye göre) | 31 (+10 önceki Ç'ye göre) | 79 (+17 önceki Ç'ye göre) | 49 (+7 önceki Ç'ye göre) | +7.3M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| BlackRock, Inc. | $99.813.069 | 4.145.061 | 8,38% | Hisse senetleri |
| TANG CAPITAL MANAGEMENT LLC | $98.725.592 | 4.099.900 | 8,29% | Hisse senetleri |
| MONTANOVA CAPITAL, LLC | $98.554.239 | 4.092.784 | 8,27% | Hisse senetleri |
| STATE STREET CORP | $81.803.372 | 3.397.150 | 6,87% | Hisse senetleri |
| VANGUARD GROUP INC | $73.935.857 | 2.561.880 | 6,20% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $55.327.990 | 2.297.674 | 4,64% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $38.001.394 | 1.578.131 | 3,19% | Hisse senetleri |
| RA CAPITAL MANAGEMENT, L.P. | $36.308.884 | 1.507.844 | 3,05% | Hisse senetleri |
| Boxer Capital Management, LLC | $33.595.356 | 1.395.156 | 2,82% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $33.049.660 | 1.372.286 | 2,77% | Hisse senetleri |
| FMR LLC | $27.396.529 | 1.137.730 | 2,30% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $25.637.976 | 1.064.700 | 2,15% | Alım opsiyonu |
| PERCEPTIVE ADVISORS LLC | $24.080.000 | 1.000.000 | 2,02% | Alım opsiyonu |
| CITADEL ADVISORS LLC | $19.611.812 | 814.444 | 1,65% | Hisse senetleri |
| MERCER GLOBAL ADVISORS INC /ADV | $19.329.786 | 802.732 | 1,62% | Hisse senetleri |
| Soleus Capital Management, L.P. | $18.342.627 | 761.737 | 1,54% | Hisse senetleri |
| MORGAN STANLEY | $16.483.121 | 684.515 | 1,38% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $15.316.975 | 636.087 | 1,29% | Hisse senetleri |
| UBS Group AG | $14.921.437 | 619.661 | 1,25% | Hisse senetleri |
| DG Capital Management, LLC | $14.727.208 | 611.595 | 1,24% | Hisse senetleri |
| Ikarian Capital, LLC | $14.549.497 | 604.215 | 1,22% | Hisse senetleri |
| DIADEMA PARTNERS LP | $12.868.352 | 534.400 | 1,08% | Satım opsiyonu |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $12.714.240 | 528.000 | 1,07% | Satım opsiyonu |
| NORTHERN TRUST CORP | $12.125.051 | 503.532 | 1,02% | Hisse senetleri |
| PERCEPTIVE ADVISORS LLC | $12.040.000 | 500.000 | 1,01% | Satım opsiyonu |
| Balyasny Asset Management L.P. | $11.723.011 | 486.836 | 0,98% | Hisse senetleri |
| SB Capital Management Inc | $11.544.028 | 400.001 | 0,97% | Hisse senetleri |
| CITADEL ADVISORS LLC | $11.394.656 | 473.200 | 0,96% | Alım opsiyonu |
| Caption Management, LLC | $10.802.288 | 448.600 | 0,91% | Alım opsiyonu |
| J. Goldman & Co LP | $10.289.890 | 427.321 | 0,86% | Hisse senetleri |
| Jones Hill Capital LP | $10.131.684 | 420.751 | 0,85% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $8.970.739 | 372.539 | 0,75% | Hisse senetleri |
| JPMORGAN CHASE & CO | $8.685.239 | 362.501 | 0,73% | Hisse senetleri |
| Ikarian Capital, LLC | $8.428.000 | 350.000 | 0,71% | Alım opsiyonu |
| DIADEMA PARTNERS LP | $7.929.544 | 329.300 | 0,67% | Alım opsiyonu |
| D. E. Shaw & Co., Inc. | $7.585.200 | 315.000 | 0,64% | Alım opsiyonu |
| GROUP ONE TRADING LLC | $6.564.425 | 272.609 | 0,55% | Hisse senetleri |
| CITADEL ADVISORS LLC | $6.222.272 | 258.400 | 0,52% | Satım opsiyonu |
| BANK OF AMERICA CORP /DE/ | $6.049.739 | 251.235 | 0,51% | Hisse senetleri |
| RTW INVESTMENTS, LP | $6.020.000 | 250.000 | 0,51% | Hisse senetleri |
| Nuveen, LLC | $5.697.617 | 236.612 | 0,48% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $5.632.938 | 233.926 | 0,47% | Hisse senetleri |
| Palo Alto Investors LP | $5.532.693 | 229.763 | 0,46% | Hisse senetleri |
| Trexquant Investment LP | $4.762.855 | 197.793 | 0,40% | Hisse senetleri |
| RAYMOND JAMES FINANCIAL INC | $4.740.292 | 196.856 | 0,40% | Hisse senetleri |
| Caption Management, LLC | $4.659.480 | 193.500 | 0,39% | Satım opsiyonu |
| BOOTHBAY FUND MANAGEMENT, LLC | $4.646.525 | 192.962 | 0,39% | Hisse senetleri |
| Moody Aldrich Partners LLC | $4.280.316 | 177.754 | 0,36% | Hisse senetleri |
| Bank of New York Mellon Corp | $3.895.348 | 161.767 | 0,33% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $3.875.387 | 160.938 | 0,33% | Hisse senetleri |
Aktivistler ve %5+ sahipler 12 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| NANCELOU, INC., LOUIS GRASMICK, NANCY GRASMICK, GRANT GRASMICK ×4 başvurular | 21 Mart 2016 | · | İlk başvuru | Pasif yatırım | SEC |
| Linda Marbán, Ph.D. ×2 başvurular | 21 Mart 2016 | · | İlk başvuru | Pasif yatırım | SEC |
| CONISTON CORPORATION, LOUIS MANZO ×4 başvurular | 21 Mart 2016 | · | İlk başvuru | Pasif yatırım | SEC |
| Frank Litvack ×2 başvurular | 13 Mart 2015 | · | İlk başvuru | Pasif yatırım | SEC |
| MD BTI, LLC, Edward St. John, LLC, Edward A. St. John | 19 Mart 2014 | · | İlk başvuru | Pasif yatırım | SEC |
| Iota Investors LLC, Wexford Spectrum Investors LLC, Wexford Capital LP, Wexford GP LLC, Charles E. Davidson, Joseph M. Jacobs ×3 başvurular | 05 Aralık 2013 | · | İlk başvuru | · | SEC |
| Eduardo Marbán, M.D., Ph.D. | 03 Aralık 2013 | · | İlk başvuru | Pasif yatırım | SEC |
| Joshua A. Kazam | 25 Eylül 2007 | · | İlk başvuru | M&A / satış | SEC |
| David M. Tanen | 25 Eylül 2007 | · | İlk başvuru | M&A / satış | SEC |
| Peter M. Kash | 25 Eylül 2007 | · | İlk başvuru | M&A / satış | SEC |
| Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi, Açıklanmayan raporlama kişisi | 24 Eylül 2007 | · | İlk başvuru | Yönetim kurulu kampanyası | SEC |
| Açıklanmayan raporlama kişisi | 22 Ağustos 2006 | · | İlk başvuru | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 33 içeriden öğrenenler · 12 yöneticiler · 18 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Linda Marban | CHIEF EXECUTIVE OFFICER | 05 Ocak 2026 A | 211.104 | 0 | 0 | $0 |
| Peter M Strumph | Chief Executive Officer | 16 Ocak 2009 A | 7.580 | 0 | 0 | $0 |
| Anthony Bergmann | CHIEF FINANCIAL OFFICER | 25 Haziran 2026 M | 11.223 | 0 | 5 | $-2.304.908 |
| Leland Gershell | CHIEF FINANCIAL OFFICER | 16 Mart 2016 P | 2.100 | 0 | 0 | $0 |
| Daron Evans | Chief Financial Officer | 30 Mart 2012 P | 25.652 | 0 | 0 | $0 |
| Karen Krasney | EVP, GENERAL COUNSEL | 25 Haziran 2026 M | 30.547 | 0 | 5 | $-2.304.658 |
| Michael T Maurer | CHIEF COMMERCIAL OFFICER | 26 Mayıs 2026 A | · | 0 | 0 | $0 |
| Deborah Ascheim | Chief Medical Officer | 24 Temmuz 2018 A | · | 0 | 0 | $0 |
| Rachel Smith | Vice President of R&D | 22 Aralık 2017 M | 18.504 | 0 | 0 | $0 |
| Andrew Warwick Hamer | VP of Medical Affairs | 03 Mart 2015 A | · | 0 | 0 | $0 |
| Hsiao Lieu | Executive VP, Clinical Dev. | 30 Mart 2012 P | 12.600 | 0 | 0 | $0 |
| Richard B Brewer | Executive Chairman | 30 Mart 2012 P | 125.000 | 0 | 0 | $0 |
| Karimah Es Sabar | Yönetim kurulu üyesi | 02 Nisan 2026 M | 0 | 0 | 3 | $-3.756.690 |
| Mike Kelliher | Yönetim kurulu üyesi | 05 Ocak 2026 A | · | 0 | 0 | $0 |
| Paul Gisbert Auwaerter | Yönetim kurulu üyesi | 05 Ocak 2026 A | 5.000 | 0 | 0 | $0 |
| Philip J Gotwals | Yönetim kurulu üyesi | 05 Ocak 2026 A | · | 0 | 0 | $0 |
| George W Dunbar JR | Yönetim kurulu üyesi | 05 Ocak 2026 A | 14.306 | 0 | 0 | $0 |
| Earl M Collier JR | Yönetim kurulu üyesi | 27 Şubat 2025 M | 57.606 | 0 | 0 | $0 |
| Louis Manzo | Yönetim kurulu üyesi | 21 Şubat 2023 M | 62.147 | 0 | 0 | $0 |
| Joshua A Kazam | Yönetim kurulu üyesi | 02 Ocak 2018 A | 38.084 | 0 | 0 | $0 |
| Louis J Grasmick | Yönetim kurulu üyesi | 16 Mart 2016 P | 1.059.740 | 0 | 0 | $0 |
| Gregory W Schafer | Yönetim kurulu üyesi | 03 Mart 2015 A | 100 | 0 | 0 | $0 |
| Peter M Kash | Yönetim kurulu üyesi | 18 Temmuz 2011 J | 1.596.208 | 0 | 0 | $0 |
| Mieyal Paul A | Yönetim kurulu üyesi | 10 Mayıs 2011 A | · | 0 | 0 | $0 |
| Arie Belldegrun | Yönetim kurulu üyesi | 10 Mayıs 2011 A | · | 0 | 0 | $0 |
| Pedro P Granadillo | Yönetim kurulu üyesi | 10 Mayıs 2011 A | · | 0 | 0 | $0 |
| David M Tanen | Yönetim kurulu üyesi | 21 Temmuz 2009 A | 1.520.705 | 0 | 0 | $0 |
| Nippon Shinyaku Co Ltd | 10% sahip | 20 Eylül 2024 P | 7.090.351 | 0 | 0 | $0 |
| CEDARS SINAI MEDICAL CENTER | 10% sahip | 09 Mayıs 2017 P | 4.049.959 | 0 | 0 | $0 |
| Eduardo Marban | 10% sahip | 19 Ağustos 2015 P | 268.557 | 0 | 0 | $0 |
| Frank Litvack | · | 13 Mayıs 2026 M | 133.776 | 0 | 0 | $0 |
| David B Musket | · | 05 Ocak 2026 A | 81.692 | 0 | 0 | $0 |
| Xavier Avat | · | 17 Nisan 2023 S | 0 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 19 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| IBRN · iShares Trust | 0,46% | 4.102 SH | 11 Eylül 2026 | Günlük |
| VFMO · VANGUARD WELLINGTON FUND | 0,10% | 85.131 SH | 19 Ağustos 2026 | Günlük |
| BBC · ETFis Series Trust I | 0,10% | 12.047 NS | 31 Temmuz 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,08% | 57.651 SH | 19 Ağustos 2026 | Günlük |
| LABU · Direxion Shares ETF Trust | 0,06% | 73.804 NS | 31 Temmuz 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,04% | 309.586 SH | 19 Ağustos 2026 | Günlük |
| IWO · iShares Trust | 0,03% | 512.267 SH | 11 Eylül 2026 | Günlük |
| VHT · VANGUARD WORLD FUND | 0,02% | 139.201 SH | 19 Ağustos 2026 | Günlük |
| PWS · Pacer Funds Trust | 0,02% | 1.008 NS | 31 Temmuz 2026 | N-PORT |
| IWM · iShares Trust | 0,01% | 1.374.951 SH | 11 Eylül 2026 | Günlük |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 591.352 SH | 19 Ağustos 2026 | Günlük |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,01% | 14.178 NS | 31 Temmuz 2026 | N-PORT |
| RSSL · Global X Funds | 0,01% | 25.706 NS | 31 Temmuz 2026 | N-PORT |
| WSML · iShares Trust | 0,00% | 3.017 SH | 11 Eylül 2026 | Günlük |
| FHLC · FIDELITY COVINGTON TRUST | 0,00% | 21.985 NS | 31 Temmuz 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 67.131 SH | 11 Eylül 2026 | Günlük |
| IWV · iShares Trust | 0,00% | 13.194 SH | 11 Eylül 2026 | Günlük |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.655.365 SH | 19 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 4.427 SH | 19 Ağustos 2026 | Günlük |
CAPR Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 16 analist
AL
Medyan hedef
$25.00
+179,3%
3 18,8%
Güçlü Al
4 25,0%
Al
9 56,2%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
5 analist · 2026-10-01Ortalama hedef $27.00 +201,7%
Şimdi
Mevcut fiyat $8.95
Düşük$7.00
Ortalama$27.00
Yüksek$54.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| CAPR | $1.66B | -12.8 | -11.6% | · | -51.1% | · |
| MPLT | $773M | -0.9 | · | · | -151.1% | · |
| MNPR | · | · | · | · | · | · |
| CBIO | $327M | -24.2 | -86.7% | -1419.6% | -90.0% | · |
| NGNE | $319M | -4.9 | · | · | -33.6% | · |
| ZURA | · | · | · | · | · | · |
| PROK | · | · | 1075.0% | -7725.2% | 6.9% | · |
| PBYI | $300M | 9.8 | -0.91% | 13.6% | 26.5% | · |
| RGNX | $733M | -3.8 | 104.5% | -113.8% | -122.5% | · |
| OVID | $212M | -4.0 | 1181.3% | -240.1% | -18.7% | · |
| ASMB | $539M | -61.8 | 153.5% | -8.5% | -5.5% | · |
Son Haberler Bu şirketten bahseden son manşetler
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 14, 2026